190 related articles for article (PubMed ID: 37166908)
1. Skin and bones: systemic mastocytosis and bone.
Wang M; Seibel MJ
Endocrinol Diabetes Metab Case Rep; 2023 May; 2023(2):. PubMed ID: 37166908
[TBL] [Abstract][Full Text] [Related]
2. Mastocytosis and related entities: a practical roadmap.
Beyens M; Elst J; van der Poorten ML; Van Gasse A; Toscano A; Verlinden A; Vermeulen K; Maes MB; Oude Elberink JNGH; Ebo D; Sabato V
Acta Clin Belg; 2023 Aug; 78(4):325-335. PubMed ID: 36259506
[TBL] [Abstract][Full Text] [Related]
3. Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease.
Gülen T; Hägglund H; Dahlén B; Nilsson G
J Intern Med; 2016 Mar; 279(3):211-28. PubMed ID: 26347286
[TBL] [Abstract][Full Text] [Related]
4. Endocrine manifestations of systemic mastocytosis in bone.
Greene LW; Asadipooya K; Corradi PF; Akin C
Rev Endocr Metab Disord; 2016 Sep; 17(3):419-431. PubMed ID: 27239674
[TBL] [Abstract][Full Text] [Related]
5. Solitary mastocytoma presenting in an adult: report and literature review of adult-onset solitary cutaneous mastocytoma with recommendations for evaluation and treatment.
Cohen PR
Dermatol Pract Concept; 2016 Jul; 6(3):31-8. PubMed ID: 27648381
[TBL] [Abstract][Full Text] [Related]
6. Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients.
Theoharides TC; Boucher W; Spear K
Int Arch Allergy Immunol; 2002 Aug; 128(4):344-50. PubMed ID: 12218373
[TBL] [Abstract][Full Text] [Related]
7. Systemic mastocytosis presenting as osteoporosis: a clinical and histomorphometric study.
Chines A; Pacifici R; Avioli LV; Teitelbaum SL; Korenblat PE
J Clin Endocrinol Metab; 1991 Jan; 72(1):140-4. PubMed ID: 1986013
[TBL] [Abstract][Full Text] [Related]
8. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
[TBL] [Abstract][Full Text] [Related]
9. Novel approaches to treating advanced systemic mastocytosis.
Gilreath JA; Tchertanov L; Deininger MW
Clin Pharmacol; 2019; 11():77-92. PubMed ID: 31372066
[TBL] [Abstract][Full Text] [Related]
10. Transglutaminase 2 expressed in mast cells recruited into skin or bone marrow induces the development of pediatric mastocytosis.
Ahn YM; Hong GU; Kim SH; Lee HJ; Baek HS; Kim MN; Park KY; Ro JY
Pediatr Allergy Immunol; 2015 Aug; 26(5):438-45. PubMed ID: 25952500
[TBL] [Abstract][Full Text] [Related]
11. KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosis.
Broesby-Olsen S; Kristensen T; Vestergaard H; Brixen K; Møller MB; Bindslev-Jensen C;
J Allergy Clin Immunol; 2013 Sep; 132(3):723-728. PubMed ID: 23587333
[TBL] [Abstract][Full Text] [Related]
12. Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis.
Berezowska S; Flaig MJ; Ruëff F; Walz C; Haferlach T; Krokowski M; Kerler R; Petat-Dutter K; Horny HP; Sotlar K
Mod Pathol; 2014 Jan; 27(1):19-29. PubMed ID: 23807778
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis.
Rossini M; Zanotti R; Orsolini G; Tripi G; Viapiana O; Idolazzi L; Zamò A; Bonadonna P; Kunnathully V; Adami S; Gatti D
Osteoporos Int; 2016 Aug; 27(8):2411-21. PubMed ID: 26892042
[TBL] [Abstract][Full Text] [Related]
14. Avapritinib treatment of aggressive systemic mastocytosis with a novel KIT exon 17 mutation.
Sandow L; Town A; Heinrich MC
Leuk Res Rep; 2024; 21():100409. PubMed ID: 38273969
[TBL] [Abstract][Full Text] [Related]
15. [Systemic mastocytosis: bone impact].
Spivacow FR; Sarli M; Nakutny R
Medicina (B Aires); 2012; 72(3):201-6. PubMed ID: 22763156
[TBL] [Abstract][Full Text] [Related]
16. Proposed European Competence Network on Mastocytosis-American Initiative in Mast Cell Diseases (ECNM-AIM) Response Criteria in Advanced Systemic Mastocytosis.
Gotlib J; Schwaab J; Shomali W; George TI; Radia DH; Castells M; Carter MC; Hartmann K; Álvarez-Twose I; Brockow K; Bonadonna P; Hermine O; Niedoszytko M; Hoermann G; Sperr WR; Elberink HO; Siebenhaar F; Butterfield JH; Ustun C; Zanotti R; Triggiani M; Schwartz LB; Lyons JJ; Orfao A; Sotlar K; Horny HP; Arock M; Metcalfe DD; Akin C; Lübke J; Valent P; Reiter A
J Allergy Clin Immunol Pract; 2022 Aug; 10(8):2025-2038.e1. PubMed ID: 35724948
[TBL] [Abstract][Full Text] [Related]
17. Mastocytosis: state of the art.
Horny HP; Sotlar K; Valent P
Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
[TBL] [Abstract][Full Text] [Related]
18. Adult mastocytosis: a review of the Santo António Hospital 's experience and an evaluation of World Health Organization criteria for the diagnosis of systemic disease.
Fernandes IC; Teixeira Mdos A; Freitas I; Selores M; Alves R; Lima M
An Bras Dermatol; 2014; 89(1):59-66. PubMed ID: 24626649
[TBL] [Abstract][Full Text] [Related]
19. Systemic mastocytosis presenting as osteoporosis--a case report.
Mathew R; Dhillon V; Shepherd P
Clin Rheumatol; 2009 Jul; 28(7):865-6. PubMed ID: 19305945
[TBL] [Abstract][Full Text] [Related]
20. Frequency of isolated cutaneous involvement in adult mastocytosis: a cohort study.
Fradet M; Negretto M; Tournier E; Laurent C; Apoil PA; Evrard S; Degboe Y; Del Mas V; Lamant L; Dubreuil P; Laroche M; Mailhol C; Hermine O; Paul C; Bulai Livideanu C
J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1713-1718. PubMed ID: 31009132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
